Influence of predialysis comorbidity and damage accrual on mortality in lupus patients treated with peritoneal dialysis
- 8 June 2010
- journal article
- Published by SAGE Publications in Lupus
- Vol. 19 (10), 1210-1218
- https://doi.org/10.1177/0961203310370043
Abstract
Objective: Although there have been many studies on systemic lupus erythematosus (SLE) patients, there are few data about survival analysis of lupus patients receiving dialysis. Therefore, the objective of this study is to analyze risk factors predicting mortality in lupus patients treated with peritoneal dialysis (PD). In addition, we also delineate the relationship between predialysis comorbid illnesses, damage accrual, and mortality in lupus patients undergoing PD. Methods: This longitudinal cohort study included 38 lupus patients undergoing PD between 1990 and 2008. The clinical parameters, disease activity (non-renal SLEDAI, nrSLEDAI), comorbid illnesses, and damage accrual were collected. We applied the Charlson Comorbidity Index (CCI), Khan Index, and Davies Index to elucidate the impact of predialysis comorbidity on mortality. Moreover, we examined prognostic value of predialysis SDI (Systemic Lupus International Collaborating Clinics Disease Damage Index) for lupus PD patients. Results: There were 33 women and five men included for analysis. The mean age at PD entry was 32.2 ± 10.4 years and mean duration of PD was 39.7 ± 22.4 months. The nrSLEDAI score during PD significantly decreased, compared to the predialysis one (2.13 ± 2.09 vs. 4.00 ± 3.08, p < 0.001). All comorbidity indices and SDI scores were significantly and positively correlated with each other (p < 0.001). Univariate Cox regression analysis showed that serum creatinine level, date at PD entry, and the CCI were predictors for mortality. The predialysis nrSLEDAI and SDI scores did not have roles in predicting mortality of lupus PD patients. Conclusions: The predialysis CCI, instead of SDI, determines an increased risk for mortality in lupus patients treated with PD. The prognosis of lupus patients treated with PD largely depends on the severity of predialysis comorbidity, especially cardiovascular diseases.Keywords
This publication has 29 references indexed in Scilit:
- Impact of Renal Survival on the Course and Outcome of Systemic Lupus Erythematosus Patients Treated With Chronic Peritoneal DialysisTherapeutic Apheresis and Dialysis, 2010
- Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 yearsRheumatology, 2009
- Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort studyLupus, 2008
- Do the Y‐set and double‐bag systems reduce the incidence of CAPD peritonitis?Nephrology Dialysis Transplantation, 2001
- Charlson Comorbidity Index as a Predictor of Outcomes in Incident Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 2001
- Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survivalAmerican Journal of Kidney Diseases, 1995
- Serum albumin is a strong predictor of death in chronic dialysis patientsKidney International, 1993
- Death Risk in CAPD PatientsNephron, 1993
- DIALYSIS AND TRANSPLANTATION IN PATIENTS WITH RENAL FAILURE DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS. THE AUSTRALIAN AND NEW ZEALAND EXPERIENCEAustralian and New Zealand Journal of Medicine, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987